Deerfield, Illinois, Feb. 27, 2025 (GLOBE NEWSWIRE) -- DEERFIELD, IL. February 27, 2025 – Vantage Specialty Chemicals, Inc., (Vantage) today announced that its VYCERIN™ API Glycerin, USP is listed on ...

DFE Pharma has launched its Continuous Manufacturing (CM) platform, designed to support pharmaceutical companies in ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast projects the global active pharmaceutical ingredient market to expand from ...

Pharmaceutical companies are increasingly focusing on acquisitions in the Active Pharmaceutical Ingredients (API) and formulation space to consolidate market share and diversify portfolios, global ...

The pharmaceutical manufacturing market is poised for growth by leveraging advanced technologies, digital platforms, and robust supply chain strategies. Opportunities arise in adopting ...

Inhaled drug formulation involves consideration of multiple factors, including the properties of the API, the needs of the target patient population, the delivery requirements, and the choice of ...

DUBLIN, May 10, 2021 /PRNewswire/ -- The "Global Active Pharmaceutical Ingredient Market (2020-2025) by Type, Molecule, Product Type, Formulation Type, Manufacturing Type, Synthesis Type, Drug Type, ...

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...

Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...

Pharmaceutical company, Nectar Lifesciences, has sold its core API and formulation business and its Menthol Assets to Ceph Lifesciences in a deal worth Rs 1290 crore Pharmaceutical company, Nectar ...

Patient-centric drug development improves adherence and outcomes by focusing on patient needs and preferences, with regulatory support from bodies like the FDA. Special populations, including ...